Use of surrogate endpoints vs. clinical outcome trials for registration trials

被引：0
|
作者：
Calvo, G. [1 ]
Suarez, M. L. [2 ]
Ruiz, M. [2 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] AEMPS, Madrid, Spain
来源：
PROCEEDINGS OF THE 8TH CONGRESS OF THE EUROPEAN ASSOCIATION FOR CLINICAL PHARMACOLOGY AND THERAPEUTICS | 2007年
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：5 / +
页数：2
相关论文
共 50 条
  • [41] Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials
    Shi, Qian
    Sargent, Daniel J.
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (02) : 102 - 111
  • [42] Surrogate endpoints in clinical trials: when is good...good enough?
    Schnuck, Jamie Olapo
    Chauhan, Sardar Shahmir B.
    Sham, Jonathan G.
    HEPATOBILIARY SURGERY AND NUTRITION, 2024, 13 (06) : 1062 - 1064
  • [43] Screening for ovarian cancer: What are the optimal surrogate endpoints for clinical trials?
    Karlan, BY
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 227 - 232
  • [44] Surrogate end point fallacies -: The urge for randomized trials with clinical endpoints
    Muehlhauser, Ingrid
    Meyer, Gabriele
    PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE, 2006, 56 (05) : 193 - 201
  • [45] The meta-analytic framework for the evaluation of surrogate endpoints in clinical trials
    Molenbergh, Geert
    Burzykowski, Tomasz
    Alonso, Ariel
    Assam, Pryseley
    Tilahun, Abel
    Buyse, Marc
    JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2008, 138 (02) : 432 - 449
  • [46] Proceedings of the University of Pennsylvania 7th annual conference on statistical issues in clinical trials: The use of biomarkers and surrogate endpoints in clinical trials
    Ellenberg, Susan S.
    Ellenberg, Jonas H.
    CLINICAL TRIALS, 2015, 12 (04) : 297 - 298
  • [47] Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials
    Qian Shi
    Daniel J. Sargent
    International Journal of Clinical Oncology, 2009, 14 : 102 - 111
  • [48] Binary surrogate endpoints in clinical trials from the perspective of case definitions
    Hahn, Andreas
    Podbielski, Andreas
    Heimesaat, Markus M.
    Frickmann, Hagen
    Warnke, Philipp
    EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY, 2021, 11 (01): : 18 - 22
  • [49] Statistical evaluation of surrogate endpoints with examples from cancer clinical trials
    Buyse, Marc
    Molenberghs, Geert
    Paoletti, Xavier
    Oba, Koji
    Alonso, Ariel
    Van der Elst, Wim
    Burzykowski, Tomasz
    BIOMETRICAL JOURNAL, 2016, 58 (01) : 104 - 132
  • [50] Response-Adaptive Randomization Procedure in Clinical Trials with Surrogate Endpoints
    Gao, Jingya
    Hu, Feifang
    Ma, Wei
    STATISTICS IN MEDICINE, 2024, 43 (30) : 5911 - 5921
12345